Prosecution Insights
Last updated: April 19, 2026

Examiner: BASQUILL, SEAN M

Tech Center 1600 • Art Units: 1612 1613 1614

This examiner grants 38% of resolved cases

Performance Statistics

38.5%
Allow Rate
-21.5% vs TC avg
1100
Total Applications
+22.7%
Interview Lift
1137
Avg Prosecution Days
Based on 1048 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
9.3%
§102 Novelty
53.1%
§103 Obviousness
18.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17810142 STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION Non-Final OA AMGEN INC.
18391727 FIBERS COMPRISING POLYESTERAMIDE COPOLYMERS FOR DRUG DELIVERY Non-Final OA DSM IP Assets B.V.
19279603 TAMPER RESISTANT DOSAGE FORMS Non-Final OA PURDUE PHARMACEUTICALS L.P.
18208029 POLYMERS AND USES THEREOF Non-Final OA Hoffmann-La Roche Inc.
17936208 Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response Non-Final OA NORTHWESTERN UNIVERSITY
18043764 PATCH AND PRODUCTION METHOD THEREOF Final Rejection KANEKA CORPORATION
17796606 TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE Final Rejection Japan Tobacco Inc.
18044877 PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18266542 COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES Non-Final OA University of Kentucky Research Foundation
17788266 HAIR COSMETIC COMPOSITION Non-Final OA KAO CORPORATION
18292286 COMPOSITION FOR LIGHTENING KERATIN FIBRES, COMPRISING A PEROXYGENATED SALT, CARBONATE AND/OR AMMONIUM BICARBONATE AND AT LEAST 1% OF A POLYPHOSPHORUS DERIVATIVE Non-Final OA L'Oreal
19060024 DISINFECTANT COMPOSITION Non-Final OA Whiteley Corporation Pty. Ltd.
16620079 POWDERED THICKENER MAINTAINING ITS EXTENSIONAL PROPERTIES WHEN RECONSTITUTED AND FOR PROMOTING SAFE SWALLOWING BY INDIVIDUALS WITH DYSPHAGIA Final Rejection SOCIETE DES PRODUiTS NESTLE S.A
18540254 CATIONIC AMPHIPHILIC POLYMERS FOR CODELIVERY OF HYDROPHOBIC AGENTS AND NUCLEIC ACIDS Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
18041420 A STORAGE STABLE INSECTICIDAL COMPOSITION Final Rejection UPL Limited
18685051 MAGNESIUM OXIDE TABLETS Non-Final OA SETOLAS Holdings, Inc.
18171406 Intravaginal Ring Device for the Delivery of Aromatase Inhibitor Non-Final OA Celanese EVA Performance Polymers LLC
18287381 DIETARY COMPOSITIONS TO EXTEND LONGEVITY WHILE MAXIMIZING STRENGTH AND FUNCTION Non-Final OA ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS
18489133 PHARMACEUTICAL COMPOSITION Final Rejection MEXICHEM FLUOR S.A. DE C.V.
18552434 ORAL CAPSULE OF PARP INHIBITOR AND PREPARATION METHOD THEREOF Non-Final OA Impact Therapeutics (Shanghai), Inc
18458828 OCULAR DRUG DELIVERY Non-Final OA Waterford Institute of Technology
18204780 NANOSPHERE AND USE THEREOF Final Rejection CHANG GUNG UNIVERSITY
18265042 TIMED-ELUTION MASKING PARTICLES AND ORAL PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Non-Final OA TOWA PHARMACEUTICAL CO., LTD.
18201107 PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS Final Rejection MALAYSIAN PALM OIL BOARD (MPOB)
18253878 BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF Final Rejection SAILING PHARMACEUTICAL TECHNOLOGY GROUP CO., LTD
18031784 DENTAL KIT COMPRISING A DENTAL ALIGNER OR A MOUTH TRAY AND DISSOLVABLE FILMS Non-Final OA BSOLVE LIMITED
17605346 TOOTH WHITENING FILM, PROCESS OF MANUFACTURING THEREOF AND A METHOD OF USING SUCH A FILM Non-Final OA BSolve Limited
18030439 CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES Final Rejection Max Biology Co. Ltd.
17776723 PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY Final Rejection Shanghai Ethypharm Pharmaceuticals Co. Ltd.
17251802 AMPHIPHILIC POLYMERS, PROCESS OF PREPARING SAME AND USES THEREOF Final Rejection TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month